Cytokines, such as TNF-α, IL-1, IL-6, and IL-17, are implicated in disease progression, their exact contribution and potential as biomarkers for diagnosis and treatment monitoring in RA patients require further exploration. The gene discussed is IL17A; the disease is rheumatoid arthritis.